The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...